CDC’s Antibiotic Resistance (AR) Solutions Initiative : Microbiome

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

CDC’s Antibiotic Resistance (AR) Solutions Initiative : Microbiome

Published Date:

10/20/17

Language:

English

[PDF-408.79 KB]

Details:

Alternative Title:

CDC’s applied research on the human microbiome aims to identify effective public health approaches to protect people, their microbiomes, and the effectiveness of antibiotics. ; Bacteria, fungi, viruses, and other microbes (germs) live naturally on our skin and in our gut and other places within our body. These microbes make up a community called the microbiome. Antibiotics can destroy your microbiome the way a wild re can destroy a forest. ; Learn more about CDC’s investments to study the microbiome at www.cdc.gov/DrugResistance. ; CS278374I ; ARSI-Microbiome-Infographic-2017.pdf ;

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion.

Subject:

[+]

Document Type:

Poster

Collection(s):

Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Pennsylvania

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

12/21/17

Series:

CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2017
AR solutions In action

Description:

$3,530,799 Funding for AR Activities Fiscal Year 2017Funding to local health departments:$897,445 (Includes funding to Philadelphia) - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. ...

File Type:

[PDF - 387.26 KB]
National Center for Emerging and Zoonotic Infectious Diseases top 10 accomplishements

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.)

Published Date:

1/31/17

Description:

Number 1: Leading the response to the outbreak of ZikaNumber 2: Transforming the nation’s fight against antibiotic resistanceNumber 3: Hunting for—and finding—emerging and dangerous infectious threatsNumber 4: Applying new technologies to advan...

File Type:

[PDF - 9.95 MB]
Antibiotic use in the United States, 2017

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.)

Published Date:

2017

Description:

The Centers for Disease Control and Prevention (CDC) focuses on helping healthcare providers deliver the best possible care for patients every day. Research shows that one way we can improve patient care is through better use of antibiotics.Modern me...

File Type:

[PDF - 3.91 MB]
CDC’s investments to combat antibiotic resistance threats nationwide : Michigan

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

1/14/19

Series:

CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2018
AR solutions in action

Description:

$4,117,347 Funding for AR Activities Fiscal Year 2018AR Lab Network’s National Tuberculosis Molecular Surveillance CenteSee CDC’s AR investments by state at www.cdc.gov/ARinvestments.Publication date from document properties.Michigan-CDC-AR-Inves...

File Type:

[PDF - 636.28 KB]
CDC’s Antibiotic Resistance (AR) Solutions Initiative

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion.

Published Date:

Jan. 2018

Description:

Investing to Defend the United States against Antibiotic ResistanceFor more information, visit www.cdc.gov/DrugResistanceSee the AR Investment Map www.cdc.gov/ARinvestmentsCS263680AARSI-Overview.pdf

File Type:

[PDF - 495.06 KB]